FindTrial
Sign In

Incidences of hereditary diffuse gastric cancer, CDH1 germline mutation, gastric cancer and breast cancer : A single center prospective observational study

Incidences of hereditary diffuse gastric cancer, CDH1 germline mutation, gastric cancer and breast cancer : A single center prospective observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007455
Enrollment
430
Registered
2022-06-29
Start date
2022-08-02
Completion date
Unknown
Last updated
2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have histologically confirmed diffuse gastric cancer. Patients meeting Hereditary Diffuse Gastric Cancer genetic testing criteria of 2020 International Gastric Cancer Linkage Consortium

Exclusion criteria

Exclusion criteria: Gastric cancer other than diffuse type Remnant gastric cancer Recurred gastric cancer History of previous gastrectomy History of any malignancy within recent 5 years (Except for Lobular breast cancer) Presence of severe comorbidity (e.g. cardiac, hepatic, or renal insufficiency) or coagulopathy Pregnant or lactating women Presence of psychiatric disorder that may preclude compliance Patients who cannot understand informed consent

Design outcomes

Primary

MeasureTime frame
Incidence of genetic mutation—

Secondary

MeasureTime frame
Incidences of gastric and breast cancer within the family of patients with hereditary diffuse gastric cancer—

Countries

Korea, Republic of

Contacts

Public ContactChang Seok Ko

Asan Medical Center

kochs815@naver.com+82-2-3010-0550

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026